Case Study: FTC V. Lundbeck

Law360, New York (October 20, 2011, 4:22 PM EDT) -- The U.S. Court of Appeals for the Eighth Circuit recently handed the Federal Trade Commission a significant loss as it rejected the agency's contention that an acquisition of two drugs used to treat a similar heart condition was anti-competitive because the drugs were part of the same relevant product market, over which the acquirer had gained a putative monopoly. While the case specifically involved health care markets, the decision means that both regulatory agencies and private plaintiffs will have to have price-based proof of relevant product...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.